Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
12-month Outcomes of CAFFR-guided PCI Deferral
Author(s): Chandan Deepak Bhavnani , Alan Yean Yip Fong , Keng Tat Koh , et al Added: 1 year ago

Intervention
The QFR-DECISION-PCI Study
Author(s): Samshol Sukahri , Ahmad Syadi Mahmood Zuhdi , Kok Han Chee , et al Added: 1 week ago

Prevention & Chronic Conditions

MI/ACS
View from the Thoraxcanter: ACC 22 Late-breaking Science Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 2 years ago
In this concise episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their analysis of the late-breaking trials that will be presented at ACC 2022. Trials covered in detail include: 00:39: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients… View more

Anticoagulation

Vascular Disease and Surgery
Justin E Davies
Dr Justin Davies is a Senior Research Fellow and Consultant Cardiologist at Imperial College London. He also completed his undergraduate training and continued on to complete his PhD at Imperial after being awarded a British Heart Foundation research fellowship. Now a leading clinical academic in the field of interventional cardiology, Dr Davies has pioneered several new techniques, including… View more
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 2 years ago
Learn about the key take-home messages from ACC.22 with View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this succinct review video, they summarise the top late-breaking science trials and share their take on how the new data can be translated into practice. Trials covered in detail include: 00:29: PACMAN AMI:… View more

Anticoagulation

Vascular Disease and Surgery
Shengxian Tu
Dr Shengxian Tu, PhD, FACC, FESC is Professor of biomedical engineering at Shanghai Jiao Tong University in Shanghai, China.Dr Tu received his PhD at the Leiden University Medical Center with cum laude. He is the inventor of both QFR and OFR techniques that allow for fast computation of fractional flow reserve from X-ray angiography and intracoronary optical coherence tomography, respectively. View more
ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag
Author(s): Mirvat Alasnag Added: 2 years ago
In this short and practice focused review, Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, SA) highlights some of the late-breaking clinical trials presented atACC.22from an interventionalist perspective. Trials covered in detail include: 00:58: SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure 01:46: GHATI: Improving STEMI Management Internationally: Two… View more

Intervention
William Fearon
Job title: Professor of Medicine, Director of Interventional Cardiology
Dr William Fuller Fearon is a Professor of Medicine and the Director of Interventional Cardiology at Stanford University School of Medicine.Dr Fearon graduated from Dartmouth College with his Bachelor’s in 1990. In 1994, he received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society.He completed an… View more